Filing Flows › Illumina (ILMN) › R&D spending
Illumina (ILMN) R&D spending by quarter
Illumina's R&D spending was $244M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $229M (Q3 2025) to $252M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $244M | -3% | +7% |
| Q2 2026 | $252M | +5% | +2% |
| Q1 2026 | $240M | +0.4% | -5% |
| Q4 2025 | $239M | +4% | — |
| Q3 2025 | $229M | -7% | — |
| Q2 2025 | $247M | -2% | — |
| Q1 2025 | $252M | — | — |
Q3 2026 at a glance
Illumina, Q3 2026: revenue $1.1B (+4% year over year), operating margin 27.0%, net earnings $220M, operating cash flow $419M. The chart follows the revenue to costs, profit and cash.
Questions
What is Illumina's R&D spending?
Illumina's R&D spending was $244M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Illumina's R&D spending changed?
Over the last 7 quarters it ranged from $229M (Q3 2025) to $252M (Q2 2026).